The downside of beating Ebola: No way to prove vaccines
The horrible Ebola outbreak in West Africa appears to be nearing its end, after killing about 10,000 people and infecting 24,000. That's great news — with one exception: No Ebola means no way to effectively test the experimental vaccines and antivirals rushed into development to handle the waning outbreak, and the next one.
"We just don't have sufficient cases," World Health Organization official Dr. Bruce Aylward tells the Los Angeles Times. For a Phase II clinical trial, 200 to 300 patients are typically needed, and for a more robust Phase III trial, that number grows to 2,000-3,000, the Food and Drug Administration says. Earlier testing of the drugs was hampered by disagreements over how to conduct the trials and whether it would be ethical to use placebos for a control group.
The lack of proven drugs will be a problem when the next Ebola outbreak hits. But it's probably a downside the people of Liberia, Sierra Leone, and Guinea are happy to be saddled with.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
'No war is good'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
The Week Unwrapped: will the US end child marriage?
Podcast Why some states have no lower limit on marriage age, plus Black maternal health and the price of olive oil
By The Week Staff Published
-
Perplexity AI: has Google finally met its match?
In The Spotlight Generative AI start-up provides fast, Wikipedia-like responses to search queries
By Chas Newkey-Burden, The Week UK Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published
-
Visa and Mastercard agree to lower swipe fees
Speed Read The companies will cap the fees they charge businesses when customers use their credit cards
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published
-
Feds cap credit card late fees at $8
speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
By Peter Weber, The Week US Published